Patents by Inventor Dongkyoon Kim

Dongkyoon Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BROADLY NEUTRALIZING ANTIBODIES AGAINST HIV
    Publication number: 20230002480
    Abstract: The present invention provides broadly neutralizing antibodies against HIV, compositions comprising the same and methods of use thereof.
    Type: Application
    Filed: February 22, 2022
    Publication date: January 5, 2023
    Inventors: Mohammad Sajadi, George K. Lewis, Anthony DeVico, Dongkyoon Kim, Guy Cavet
  • ANTI-HIV ANTIBODIES
    Publication number: 20210040185
    Abstract: Provided herein are anti-HIV antibodies, compositions comprising such antibodies, and methods of producing the antibodies. Additionally provided are methods of treating or preventing HIV infection, or a complication of HIV infection, using the anti-HIV antibodies.
    Type: Application
    Filed: September 9, 2020
    Publication date: February 11, 2021
    Inventors: Guy L. CAVET, Anthony Devico, Dongkyoon Kim, George K. Lewis, Shaun M. Lippow, Mohammad Sajadi
  • ANTI-HIV ANTIBODIES
    Publication number: 20210040184
    Abstract: Provided herein are anti-HIV antibodies, compositions comprising such antibodies, and methods of producing the antibodies. Additionally provided are methods of treating or preventing HIV infection, or a complication of HIV infection, using the anti-HIV antibodies.
    Type: Application
    Filed: September 9, 2020
    Publication date: February 11, 2021
    Inventors: Guy L. CAVET, Anthony Devico, Dongkyoon Kim, George K. Lewis, Shaun M. Lippow, Mohammad Sajadi, Katherine Williams
  • BROADLY NEUTRALIZING ANTIBODIES AGAINST HIV
    Publication number: 20200172601
    Abstract: The present invention provides broadly neutralizing antibodies against HIV, compositions comprising the same and methods of use thereof. Specifically, the invention provides isolated anti-HIV antibodies that are capable of neutralizing at least 95% of the HIV pseudoviruses listed in Table 1 and neutralizing 100% of the HIV clade B, G and D viruses listed in Table 1 with an IC50 value of less than 50 ug/mL. Further provides are the sequences especially complementarity-determining region (CDR) sequences of antibodies disclosed.
    Type: Application
    Filed: June 22, 2018
    Publication date: June 4, 2020
    Inventors: Mohammad Sajadi, George K. Lewis, Anthony DeVico, Amir Dashti, Marzena E. Pazgier, William David Tolbert, Dongkyoon Kim, Guy Cavet